[{"address1": "Modi\u2019in Technology Park", "address2": "2 HaMa\u2019ayan Street", "city": "Hevel Modi'in", "zip": "7177871", "country": "Israel", "phone": "972 8 642 9100", "fax": "972 8 642 9101", "website": "https://www.biolinerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.", "fullTimeEmployees": 28, "companyOfficers": [{"maxAge": 1, "name": "Ms. Mali  Zeevi CPA, CPA", "age": 48, "title": "Chief Financial Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 325000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ella  Sorani Ph.D.", "age": 56, "title": "Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 295000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Lacey", "title": "Head of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raziel  Fried", "title": "Treasurer & Budgetary Control Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.79, "open": 3.66, "dayLow": 3.65, "dayHigh": 3.86, "regularMarketPreviousClose": 3.79, "regularMarketOpen": 3.66, "regularMarketDayLow": 3.65, "regularMarketDayHigh": 3.86, "payoutRatio": 0.0, "beta": 0.885, "forwardPE": -17.454546, "volume": 22241, "regularMarketVolume": 22241, "averageVolume": 34379, "averageVolume10days": 22060, "averageDailyVolume10Day": 22060, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 16368710, "fiftyTwoWeekLow": 2.3, "fiftyTwoWeekHigh": 26.8, "allTimeHigh": 4122.0, "allTimeLow": 2.3, "priceToSalesTrailing12Months": 0.9488557, "fiftyDayAverage": 3.8784, "twoHundredDayAverage": 4.30225, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9805671424, "profitMargins": -0.45341998, "floatShares": 2450907651, "sharesOutstanding": 4262685, "sharesShort": 170691, "sharesShortPriorMonth": 203233, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.04, "heldPercentInsiders": 0.04078, "heldPercentInstitutions": 0.0155299995, "shortRatio": 5.02, "shortPercentOfFloat": 0.0401, "impliedSharesOutstanding": 3710940, "bookValue": 0.008, "priceToBook": 479.99997, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -7822000, "trailingEps": -6.0, "forwardEps": -0.22, "lastSplitFactor": "1:40", "lastSplitDate": 1738195200, "enterpriseToRevenue": 568.412, "enterpriseToEbitda": -905.417, "52WeekChange": -0.82222223, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 3.84, "targetHighPrice": 40.0, "targetLowPrice": 12.0, "targetMeanPrice": 26.0, "targetMedianPrice": 26.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 28159000, "totalCashPerShare": 0.011, "ebitda": -10830000, "totalDebt": 12603000, "quickRatio": 1.837, "currentRatio": 2.058, "totalRevenue": 17251000, "debtToEquity": 62.789, "revenuePerShare": 6.0, "returnOnAssets": -0.15356, "returnOnEquity": -0.4594, "grossProfits": 10234000, "freeCashflow": -11746375, "operatingCashflow": -21203000, "revenueGrowth": -0.944, "grossMargins": 0.59324, "ebitdaMargins": -0.62779, "operatingMargins": -7.5756598, "financialCurrency": "USD", "symbol": "BLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "BioLineRx Ltd.", "regularMarketChangePercent": 1.31926, "regularMarketPrice": 3.84, "esgPopulated": false, "corporateActions": [], "shortName": "BioLineRx Ltd.", "marketState": "CLOSED", "postMarketTime": 1758925880, "regularMarketTime": 1758916800, "postMarketPrice": 3.85, "postMarketChange": 0.00999999, "regularMarketChange": 0.049999952, "regularMarketDayRange": "3.65 - 3.86", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 34379, "fiftyTwoWeekLowChange": 1.54, "fiftyTwoWeekLowChangePercent": 0.6695652, "fiftyTwoWeekRange": "2.3 - 26.8", "fiftyTwoWeekHighChange": -22.96, "fiftyTwoWeekHighChangePercent": -0.8567164, "fiftyTwoWeekChangePercent": -82.22222, "dividendDate": 1563148800, "earningsTimestamp": 1755144000, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "earningsCallTimestampStart": 1755174600, "earningsCallTimestampEnd": 1755174600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.0, "epsForward": -0.22, "epsCurrentYear": -0.795, "priceEpsCurrentYear": -4.8301883, "fiftyDayAverageChange": -0.038400173, "fiftyDayAverageChangePercent": -0.009901035, "twoHundredDayAverageChange": -0.46225, "twoHundredDayAverageChangePercent": -0.10744378, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1311773400000, "postMarketChangePercent": 0.26041642, "exchange": "NCM", "messageBoardId": "finmb_5015080", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]